课题基金 / 基金详情

GROWTH HORMONE AND OXANDROLONE ON GROWTH IN TURNER'S SYNDROME

GROWTH HORMONE AND OXANDROLONE ON GROWTH IN TURNER'S SYNDROME
生长激素和氧雄龙对特纳综合征生长的影响
批准号：
5221643
负责人：
BARBARA M LIPPE
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5221643
关键词：
Turner's syndrome child physical development clinical research clinical trials combination chemotherapy drug screening /evaluation hormone therapy human subject human therapy evaluation middle childhood (6-11) oxandrolone pediatric pharmacology preschool child (1-5) somatotropin

项目摘要

项目成果

BARBARA M LIPPE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Multicentered, open-label, randomized, parallel clinical trial to determine if methionyl human growth hormone (GH) alone, oxandrolone alone, or the two in combination can promote growth in Turner's syndrome children, ages 4-12. Previous data indicate GH may enhance growth and that oxandrolone clearly increases growth during therapy. To determine of the combination is more efficacious than the drugs given separately.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOMATOTROPIN TREATMENT OF GROWTH RETARDATION IN IDIOPATHIC SHORT CHILDREN
HORMONE IN NEW PREMIXED LIQUID FORMULATION IN STIMULATING GROWTH
SOMATOTROPIN TREATMENT OF GROWTH RETARDATION IN IDIOPATHIC SHORT CHILDREN
SAFETY AND EFFICACY OF PROTROPIN FOR PATIENTS WITH GROWTH HORMONE DEFICIENCY